Related Experiment Video
Updated: Mar 28, 2026
Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy
Published on: September 29, 2017
SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS
Mousa Numan Ahmad1, Fares Halim Haddad2
1Department of Nutrition and Food Technology, Human Nutrition and Dietetics, The University of Jordan, Amman11942.. mosnuman@ju.edu.jo.
Insights
The visceral adiposity index (VAI) shows strong associations with cardiometabolic risks and outperforms other obesity measures in predicting these health issues. This study confirms VAI
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Health
- Obesity Research
Background:
- The visceral adiposity index (VAI) is a novel metric proposed for assessing cardiometabolic risk.
- Previous research has not definitively established the clinical utility and predictive power of VAI.
Purpose of the Study:
- To investigate the relationship between VAI and established adiposity and cardiometabolic risk markers.
- To evaluate the predictive capability of VAI for cardiometabolic risk.
- To compare the predictive performance of VAI against other common adiposity indices.
Main Methods:
- A cross-sectional study involving 1,622 Jordanian adults (686 men, 936 women; aged 20-80 years).
- Measurements included VAI, BMI, WC, WHR, WHtR, HDL-C, TG, FSG, SBP, and DBP.
- Statistical analyses included association assessments, age- and gender-specific distributions, and ROC curve analysis for predictive comparisons.
Main Results:
- VAI was higher in women than men and increased with age in both genders.
- VAI demonstrated significant correlations with TG, HDL-C, FSG, SBP, and DBP, and with WHR, WC, WHtR, and BMI.
- VAI exhibited the largest Area Under the Curve (AUC) values for risk prediction compared to other adiposity indices in both men and women.
Conclusions:
- VAI is significantly associated with cardiometabolic risk factors.
- VAI demonstrates superior predictive ability for cardiometabolic risk compared to traditional adiposity indices like BMI, WC, WHR, and WHtR.
- VAI shows promise as a valuable tool for identifying individuals at elevated cardiometabolic risk.
Introduction:
visceral adiposity index (VAI) has recently been proposed as a predictor of cardiometabolic risk, but its usefulness has not been confirmed.
Objectives:
to evaluate the association between VAI and conventional adiposity and cardiometabolic risk indices and examine VAI risk predictive ability and compare it with other adiposity indices.
Methods:
a total of 1 622 Jordanian adults, 686 men and 936 women, aged 20-80 years were included this study. VAI, body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), waist-height ratio (WHtR) were examined and high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting serum glucose (FSG), systolic (SBP), and diastolic (DBP) blood pressure were determined. Associations and age-and gender specific distribution and differences were evaluated. Receiver operating characteristic (ROC) curve and area under curve (AUC) were used for risk predictive ability comparison.
Results:
VAI of women (6.82±6.43) was higher than of men (4.15±4.62). VAI severity increased with age in a dose-response trend (p<0.001) in both genders. Women had higher prevalence than men of high risks of VAI and all adiposity and cardiometabolic indices. VAI markedly associated with TG, HDL-C, FSG, SBP and DBP or WHR, WC, WHtR and BMI in respective order of correlation potency for cardiometabolic or adiposity risk indices. In men and women respectively, the largest AUC was for VAI (0.79 vs. 0.77), followed by WHR (0.73 vs. 0.75), WC (0.69 vs. 0.74), WHtR (0.65 vs. 0.71) and BMI (0.53 vs. 0.51).
Conclusions:
the findings suggest that VAI potentially associates with cardiometabolic risks and proves to be superior to other adiposity indices in predicting such risk.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
06:22Isolation of Viable Adipocytes and Stromal Vascular Fraction from Human Visceral Adipose Tissue Suitable for RNA Analysis and Macrophage Phenotyping
Published on: October 27, 2020
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:24Obesity
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...